Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Covington
UBS
US Department of Justice
Chubb

Generated: July 21, 2019

DrugPatentWatch Database Preview

Litigation Details for Sunovion Pharmaceuticals Inc. v. Barr Laboratories, Inc. (E.D.N.C. 2008)

Try a free trialSee Plans and Pricing

« Back to Dashboard

Sunovion Pharmaceuticals Inc. v. Barr Laboratories, Inc. (E.D.N.C. 2008)

Docket ➤ Sign Up Date Filed 2008-07-30
Court District Court, E.D. North Carolina Date Terminated 2012-12-14
Cause 28:1338 Patent Infringement Assigned To Malcolm Jones Howard
Jury Demand None Referred To
Parties BARR LABORATORIES, INC.; BARR PHARMACEUTICALS, INC.; PLIVA-HRVATSKA D.O.O.; SANDOZ, INC.; SUN PHARMACEUTICAL INDUSTRIES, LTD.; SUNOVION PHARMACEUTICALS INC.; SYNTHON B.V.; SYNTHON HOLDING B.V.; SYNTHON LABORATORIES, INC.; SYNTHON PHARMACEUTICALS, INC.; UCB S.A.; UCB, INC.
Patents 5,698,558; 6,274,171
Attorneys Eric P. Stevens; F. Hill Allen , IV; James A. Dean; Jeffrey I.D. Lewis; M. Jackson Nichols; Mark A. Ash; Melody Carroll Ray-Welborn; Noel L. Allen; Robert J. Morris; Sarah L. Buthe; W. Andrew Copenhaver; W. Ellis Boyle
Firms Fried Frank Harris Shriver & Jacobson; Graebe Hanna & Welborn, PLLC; Mark A. Ash; Nichols, Choi & Lee, PLLC; Poyner & Spruill; Tharrington Smith; U. S. Court of Appeals for the Fourth Circuit; U.S. Attorney's Office; Womble Carlyle Sandridge & Rice, LLC
Link to Docket External link to docket
Small Molecule Drugs cited in Sunovion Pharmaceuticals Inc. v. Barr Laboratories, Inc.
The small molecule drugs covered by the patents cited in this case are ➤ Sign Up , ➤ Sign Up , and ➤ Sign Up .

Details for Sunovion Pharmaceuticals Inc. v. Barr Laboratories, Inc. (E.D.N.C. 2008)

Date Filed Document No. Description Snippet Link To Document
2010-03-22 182 U.S. Patent No. 5,698,558, # 2 Exhibit C - Original Claims in Prosecution History of U.S. Patent No. 5,627,183…92 in '558 Patent Prosecution History, # 4 Exhibit E - Office Action 2/3/95 in '558 Patent Prosecution…/97 in '558 Patent Prosecution History, # 6 Exhibit G - Notice of Allowance in '558 Patent Prosecution…Statement, # 8 Exhibit I - Original Patent Application of '558 Patent, # 9 Exhibit O - Screen Print of MedDRA…2008 14 December 2012 5:10-md-01500-H Patent None District Court, E.D. North External link to document
2010-03-22 183 # 10 Exhibit 16a: USP 5,698,558 File History, # 11 Exhibit 16b: USP 5,698,558 File History, # 12 Exhibit…Exhibit 16c: USP 5,698,558 File History, # 13 Exhibit 16d: USP 5,698,558 File History, # 14 Exhibit 16e: …: USP 5,698,558 File History) (Boyle, W.) (Entered: 03/22/2010) 22 March 2010 PACER Document …Exhibit 18: PLI article on patent claim drafting, # 9 Exhibit 19: manual of patent examining procedure, # …2008 14 December 2012 5:10-md-01500-H Patent None District Court, E.D. North External link to document
2010-06-25 212 not under seal) as follows: Exhibit B - US Patent No. 5,698,558 (Dec. 16, 1997) filed by Sandoz, Inc.. (…Exhibit C - US Patent No. 5,627,183 (May 6, 1997), # 2 Exhibit D - Complaint For Patent Infringement, …2008 14 December 2012 5:10-md-01500-H Patent None District Court, E.D. North External link to document
2010-09-08 235 infringement of United States Patent No. 5,698,558 (“the ‘558 patent”) by Defendants Synthon Pharmaceuticals…insufficient to cause said sedation. U.S. Patent No. 5,698,558 col. 9, ll. 60-63, col. 10 ll. 1-6 (emphasis…filed two patent applications. One of these applications led to the issuance of the ‘558 patent. The other… in U.S. Patent 5,627,183 prosecution history); DE-182, Ex. D at, e.g., 65 (double patenting rejection…meaning of disputed claims within a patent. In construing a patent claim, a court must first look External link to document
2010-09-30 250 Inc. (Attachments: # 1 Exhibit 1 - U.S. Patent No. 5,698,558, # 2 Exhibit 2 - Blaiss Opening Report, … from '558 File History, # 11 Exhibit 11 - U.S. Patent No. 5,478,941, # 12 Exhibit 12 - May 24, 2010 Hearing…2008 14 December 2012 5:10-md-01500-H Patent None District Court, E.D. North External link to document
2010-10-13 253 U.S. Patent No. 5,698,558, # 3 Exhibit 3 - Original Claims in prosecution history of U.S. Patent No. 5,627,183… in '558 patent prosecution history, # 6 Exhibit Exh. 7 - Notice of Allowance in '558 patent prosecution…2008 14 December 2012 5:10-md-01500-H Patent None District Court, E.D. North External link to document
2010-11-15 289 are the owners of United States Patent No. 5,698,558 (the ‘558 patent) which covers a method of treating…version of Xyzal prior to the expiration of the ‘558 patent. Although Sandoz’s ANDA as originally filed sought…2008 14 December 2012 5:10-md-01500-H Patent None District Court, E.D. North External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Federal Trade Commission
UBS
Merck
Cipla
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.